Feto-Maternal Outcome in COVID-19 Positive Patients with Hypertensive Disorders in Pregnancy

Background; On March 11, 2020 World Health Organization (WHO) declared corona virus disease (COVID-19) a public health emergency of international concern since its outbreak in Wuhan, China. Coronaviruses are enveloped RNA viruses that are distributed widely among humans, other mammals and birds and they cause respiratory, neurologic, hepatic and enteric diseases. Six coronavirus species are known to cause human disease and four of them - 229E, OC43, NL63, and HKU1 are less pathogenic causing common cold symptoms in immunocompetent individuals. The two other strains - severe acute respiratory syndrome coronavirus (SARS CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) - are zoonotic in origin and sometimes cause fatal illness. We described the clinical presentation, obstetric and neonatal outcomes in patients with hypertensive disorders in pregnancy associated with COVID-19 at the time of delivery. Aims and Objective: The aim of this study was to describe maternal and fetal outcomes of pregnant women with hypertensive disorders with COVID-19 infection and to prevent maternal mortality and morbidity by knowing prognostic factors and by prompt intervention. Methods: Retrospective observational analytical study conducted at department of obstetrics and gynaecology, Dr. S N Medical College, Jodhpur, a tertiary care referral hospital. Women with hypertensive disorders in pregnancy consecutively admitted for delivery and tested via nasopharyngeal (NP) swab for SARS-CoV-2 using RTPCR from 1 January 2021 to 30 June 2021 were included in the study. A total number of 60 cases of hypertensive disorders with COVID-19 positive admitted to tertiary care hospital were taken into this study. Results: From report of 60 women, who had hypertensive disorders in pregnancy with COVID-19 infections delivering 60 babies, 50% were less than25 years of age, 66.66 % was primigravida, 56.66% was less than37 weeks of gestation, 70% delivered by LSCS, 35% of complicated pregnancies need ICU.